|
|
||||||||
(Received for publication, February 19, 1997, and in revised form, April 9, 1997)
From the The carbohydrate binding specificities of three
sialoadhesins, a subgroup of I-type lectins (immunoglobulin superfamily
lectins), were compared by measuring lectin-transfected COS cell
adhesion to natural and synthetic gangliosides. The neural
sialoadhesins, myelin-associated glycoprotein (MAG) and Schwann cell
myelin protein (SMP), had similar and stringent binding specificities.
Each required an
Volume 272, Number 27,
Issue of July 4, 1997
pp. 16889-16895
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
SIALIC ACID LINKAGE AND SUBSTRUCTURE REQUIREMENTS FOR BINDING OF
MYELIN-ASSOCIATED GLYCOPROTEIN, SCHWANN CELL MYELIN PROTEIN, AND
SIALOADHESIN
,
,
,
Departments of Pharmacology and
Neuroscience, The Johns Hopkins University School of Medicine,
Baltimore, Maryland 21205, the ¶ Department of Applied Bioorganic
Chemistry, Gifu University, Gifu 501-11, Japan, the
Samuel
Lunenfeld Research Institute, Mount Sinai Hospital, Toronto M5G 1X5,
Canada, and the ** Imperial Cancer Research Fund Laboratories, John
Radcliffe Hospital, Oxford OX3 9DU, United Kingdom
2,3-linked sialic acid on the terminal galactose of
a neutral saccharide core, and they shared the following rank-order
potency of binding: GQ1b
GD1a = GT1b
GM3 = GM4
GM1, GD1b, GD3, GQ1b
(nonbinders). In contrast, sialoadhesin had less exacting specificity,
binding to gangliosides that bear either terminal
2,3- or
2,8-linked sialic acids with the following rank-order potency of
binding: GQ1b
> GD1a = GD1b = GT1b = GM3 = GM4 > GD3 = GQ1b
GM1 (nonbinder). CD22 did not bind
to any ganglioside tested. Binding of MAG, SMP, and sialoadhesin was
abrogated by chemical modification of either the sialic acid carboxylic
acid group or glycerol side chain on a target ganglioside. Synthetic ganglioside GM3 derivatives further distinguished lectin
binding specificities. Deoxy and/or methoxy derivatives of the 4-, 7-, 8-, or 9-position of sialic acid attenuated or eliminated binding of
MAG, as did replacement of the sialic acid acetamido group with a
hydroxyl. In contrast, the 4- and 7-deoxysialic acid derivatives supported sialoadhesin binding at near control levels (the other derivatives did not support binding). These data are consistent with
sialoadhesin binding to one face of the sialic acid moiety, whereas MAG
(and SMP) may have more complex binding sites or may bind sialic acids
only in the context of more restricted oligosaccharide conformations.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
P. H. H. Lopez, G. Zhang, M. A. Bianchet, R. L. Schnaar, and K. A. Sheikh Structural requirements of anti-GD1a antibodies determine their target specificity Brain, July 1, 2008; 131(7): 1926 - 1939. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. S. Yang, I. Lorenzini, K. Vajn, A. Mountney, L. P. Schramm, and R. L. Schnaar Sialidase enhances spinal axon outgrowth in vivo PNAS, July 18, 2006; 103(29): 11057 - 11062. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varki and T. Angata Siglecs--the major subfamily of I-type lectins Glycobiology, January 1, 2006; 16(1): 1R - 27R. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Vyas, O. Blixt, J. C. Paulson, and R. L. Schnaar Potent Glycan Inhibitors of Myelin-associated Glycoprotein Enhance Axon Outgrowth in Vitro J. Biol. Chem., April 22, 2005; 280(16): 16305 - 16310. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, N. L. Shaper, S. Itonori, M. Heffer-Lauc, K. A. Sheikh, and R. L. Schnaar Myelin-associated glycoprotein (Siglec-4) expression is progressively and selectively decreased in the brains of mice lacking complex gangliosides Glycobiology, September 1, 2004; 14(9): 851 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Sonnenburg, T. K. Altheide, and A. Varki A uniquely human consequence of domain-specific functional adaptation in a sialic acid-binding receptor Glycobiology, April 1, 2004; 14(4): 339 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Blixt, B. E. Collins, I. M. van den Nieuwenhof, P. R. Crocker, and J. C. Paulson Sialoside Specificity of the Siglec Family Assessed Using Novel Multivalent Probes: IDENTIFICATION OF POTENT INHIBITORS OF MYELIN-ASSOCIATED GLYCOPROTEIN J. Biol. Chem., August 15, 2003; 278(33): 31007 - 31019. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Liu, A. Fournier, T. GrandPre, and S. M. Strittmatter Myelin-Associated Glycoprotein as a Functional Ligand for the Nogo-66 Receptor Science, August 16, 2002; 297(5584): 1190 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Angata, S. C. Kerr, D. R. Greaves, N. M. Varki, P. R. Crocker, and A. Varki Cloning and Characterization of Human Siglec-11. A RECENTLY EVOLVED SIGNALING MOLECULE THAT CAN INTERACT WITH SHP-1 AND SHP-2 AND IS EXPRESSED BY TISSUE MACROPHAGES, INCLUDING BRAIN MICROGLIA J. Biol. Chem., June 28, 2002; 277(27): 24466 - 24474. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Vyas, H. V. Patel, S. E. Fromholt, M. Heffer-Lauc, K. A. Vyas, J. Dang, M. Schachner, and R. L. Schnaar From the Cover: Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration PNAS, June 11, 2002; 99(12): 8412 - 8417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. T. Lunn, T. O. Crawford, R. A. C. Hughes, J. W. Griffin, and K. A. Sheikh Anti-myelin-associated glycoprotein antibodies alter neurofilament spacing Brain, April 1, 2002; 125(4): 904 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakamura, T. Yamaji, P. R. Crocker, A. Suzuki, and Y. Hashimoto Lymph node macrophages, but not spleen macrophages, express high levels of unmasked sialoadhesin: implication for the adhesive properties of macrophages in vivo Glycobiology, March 1, 2002; 12(3): 209 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamaji, T. Teranishi, M. S. Alphey, P. R. Crocker, and Y. Hashimoto A Small Region of the Natural Killer Cell Receptor, Siglec-7, Is Responsible for Its Preferred Binding to alpha 2,8-Disialyl and Branched alpha 2,6-Sialyl Residues. A COMPARISON WITH Siglec-9 J. Biol. Chem., February 15, 2002; 277(8): 6324 - 6332. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roseman Reflections on Glycobiology J. Biol. Chem., November 2, 2001; 276(45): 41527 - 41542. [Full Text] [PDF] |
||||
![]() |
T. Angata and A. Varki Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily Glycobiology, April 1, 2000; 10(4): 431 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. M. Brinkman-Van der Linden and A. Varki New Aspects of Siglec Binding Specificities, Including the Significance of Fucosylation and of the Sialyl-Tn Epitope J. Biol. Chem., March 17, 2000; 275(12): 8625 - 8632. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. M. Brinkman-Van der Linden, E. R. Sjoberg, L. R. Juneja, P. R. Crocker, N. Varki, and A. Varki Loss of N-Glycolylneuraminic Acid in Human Evolution. IMPLICATIONS FOR SIALIC ACID RECOGNITION BY SIGLECS J. Biol. Chem., March 17, 2000; 275(12): 8633 - 8640. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Collins, T. J. Fralich, S. Itonori, Y. Ichikawa, and R. L. Schnaar Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells Glycobiology, January 1, 2000; 10(1): 11 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Collins, H. Ito, N. Sawada, H. Ishida, M. Kiso, and R. L. Schnaar Enhanced Binding of the Neural Siglecs, Myelin-associated Glycoprotein and Schwann Cell Myelin Protein, to Chol-1 (alpha -Series) Gangliosides and Novel Sulfated Chol-1 Analogs J. Biol. Chem., December 31, 1999; 274(53): 37637 - 37643. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takematsu, S. Diaz, A. Stoddart, Y. Zhang, and A. Varki Lysosomal and Cytosolic Sialic Acid 9-O-Acetylesterase Activities Can Be Encoded by One Gene via Differential Usage of a Signal Peptide-encoding Exon at the N Terminus J. Biol. Chem., September 3, 1999; 274(36): 25623 - 25631. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Chammas, J. L. Sonnenburg, N. E. Watson, T. Tai, M. G. Farquhar, N. M. Varki, and A. Varki De-N-acetyl-gangliosides in Humans: Unusual Subcellular Distribution of a Novel Tumor Antigen Cancer Res., March 1, 1999; 59(6): 1337 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. Chou, H. Takematsu, S. Diaz, J. Iber, E. Nickerson, K. L. Wright, E. A. Muchmore, D. L. Nelson, S. T. Warren, and A. Varki A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence PNAS, September 29, 1998; 95(20): 11751 - 11756. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Cornish, S. Freeman, G. Forbes, J. Ni, M. Zhang, M. Cepeda, R. Gentz, M. Augustus, K. C. Carter, and P. R. Crocker Characterization of Siglec-5, a Novel Glycoprotein Expressed on Myeloid Cells Related to CD33 Blood, September 15, 1998; 92(6): 2123 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Razi and A. Varki Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes PNAS, June 23, 1998; 95(13): 7469 - 7474. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Angata and A. Varki Cloning, Characterization, and Phylogenetic Analysis of Siglec-9, a New Member of the CD33-related Group of Siglecs. EVIDENCE FOR CO-EVOLUTION WITH SIALIC ACID SYNTHESIS PATHWAYS J. Biol. Chem., July 14, 2000; 275(29): 22127 - 22135. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. W. van Rossenberg, L. A. J. M. Sliedregt, R. Autar, C. Piperi, A. P. Van der Merwe, T. J. C. van Berkel, J. Kuiper, and E. A. L. Biessen A Structure-Function Study of Ligand Recognition by CD22beta J. Biol. Chem., April 13, 2001; 276(16): 12967 - 12973. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |